Skip to content
The Nexus
DossierENTITY

AXSM

Coverage of AXSM in the Nexus archive.

Earliest in view: Aug 10 · 11:20 UTCMost recent: Aug 10 · 11:20 UTC
Co-mentioned in this coverage
Axsome Therapeuticsorganization1Zacks Investment Researchorganization1New Yorkplace1Wall Streettopic1$218.4 milliontopic1
Recent coverage
  • BUSINESSAug 10 · 11:20 UTCWTOP DC
    Axsome: Q2 Earnings Snapshot

    Axsome Therapeutics Inc. reported a second quarter loss of $51.3 million, equating to 99 cents per share, which met Wall Street expectations. While revenue reached $218.4 million, it fell short of Street forecasts and the average estimate of $224.5 million from seven analysts.

AXSM · Dossier · The Nexus